Yesterday, High Tide announced its entry into the fast-growing German medical cannabis market by acquiring 51% of Remexian Pharma GmbH. Click the button below to view StratCann’s full coverage of the announcement.
High Tide to acquire a majority stake in Remexian Pharma GmbH, marking entry into the German market — StratCann
August 15, 2025